Nancy Scheinost
Rheumatology · Bryan, TXNPI 1740238450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,609 and has fallen 98.1% since, to $67 in 2024.
Across 279 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$803
- AstraZeneca$618
- UCB, Inc.$427
- Lilly USA, LLC$421
- GSK$303
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,914100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 53 | $1,262 |
| AbbVie | 33 | $803 |
| AstraZeneca(2 entities) | 29 | $618 |
| UCB, Inc. | 23 | $427 |
| Lilly USA, LLC | 19 | $421 |
| GSK | 8 | $303 |
| Johnson & Johnson | 8 | $286 |
| Eisai Inc. | 13 | $246 |
| Pfizer | 27 | $216 |
| Novartis | 10 | $174 |
| Boehringer Ingelheim | 4 | $173 |
| ANI Pharmaceuticals, Inc. | 11 | $141 |
| Bristol Myers Squibb | 3 | $136 |
| Organon | 12 | $136 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| Genentech USA, Inc. | 4 | $67 |
| Actelion Pharmaceuticals US, Inc. | 2 | $63 |
| Sanofi | 2 | $47 |
| Fresenius Kabi USA, LLC | 2 | $47 |
| Sandoz | 2 | $46 |
| Aurinia Pharma U.S., Inc. | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 2 | $37 |
| Pacira Therapeutics, Inc. | 2 | $30 |
| Mallinckrodt Enterprises LLC | 1 | $28 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Medexus Pharma, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,929 in reported general payments places this provider in the 55th percentile of 512 rheumatology providers in Texas.
Other rheumatology in Bryan
- John CushDallas$3.7M
- Sanjay ChabraEl Paso$3.3M
- Dhiman BasuColleyville$1.8M
- Frank WellborneNew Braunfels$1.4M
- Christopher ParkerWest Lake Hills$1.4M
- Pendleton WickershamSan Antonio$954K
- Henry TownsendPlano$738K
- Zoran KurepaDallas$483K
- Giovanni GeslaniDallas$415K
- Dianne PetroneDallas$401K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.